BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9721943)

  • 1. Regional CBF in apolipoprotein E-deficient and wild type mice during focal cerebral ischemia.
    Bart RD; Sheng H; Laskowitz DT; Pearlstein RD; Warner DS
    Neuroreport; 1998 Aug; 9(11):2615-20. PubMed ID: 9721943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein E deficiency worsens outcome from global cerebral ischemia in the mouse.
    Sheng H; Laskowitz DT; Mackensen GB; Kudo M; Pearlstein RD; Warner DS
    Stroke; 1999 May; 30(5):1118-24. PubMed ID: 10229753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of human apolipoprotein E downregulates amyloid precursor protein-induced ischemic susceptibility.
    Koistinaho M; Kettunen MI; Holtzman DM; Kauppinen RA; Higgins LS; Koistinaho J
    Stroke; 2002 Jul; 33(7):1905-10. PubMed ID: 12105373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein E-deficient mice have increased susceptibility to focal cerebral ischemia.
    Laskowitz DT; Sheng H; Bart RD; Joyner KA; Roses AD; Warner DS
    J Cereb Blood Flow Metab; 1997 Jul; 17(7):753-8. PubMed ID: 9270492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amlodipine treatment reduces stroke size in apolipoprotein E-deficient mice.
    Mogi M; Iwai M; Chen R; Iwanami J; Ide A; Tsukuda K; Yoshii T; Horiuchi M
    Am J Hypertens; 2006 Nov; 19(11):1144-9. PubMed ID: 17070425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuation of focal brain ischemia by telmisartan, an angiotensin II type 1 receptor blocker, in atherosclerotic apolipoprotein E-deficient mice.
    Iwai M; Inaba S; Tomono Y; Kanno H; Iwanami J; Mogi M; Horiuchi M
    Hypertens Res; 2008 Jan; 31(1):161-8. PubMed ID: 18360031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mouse strain differences in susceptibility to cerebral ischemia are related to cerebral vascular anatomy.
    Barone FC; Knudsen DJ; Nelson AH; Feuerstein GZ; Willette RN
    J Cereb Blood Flow Metab; 1993 Jul; 13(4):683-92. PubMed ID: 8314921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased vulnerability to focal ischemic brain injury in human apolipoprotein E4 knock-in mice.
    Mori T; Kobayashi M; Town T; Fujita SC; Asano T
    J Neuropathol Exp Neurol; 2003 Mar; 62(3):280-91. PubMed ID: 12638732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a new double-filament model of focal cerebral ischemia in heme oxygenase-2-deficient mice.
    Goto S; Sampei K; Alkayed NJ; Doré S; Koehler RC
    Am J Physiol Regul Integr Comp Physiol; 2003 Jul; 285(1):R222-30. PubMed ID: 12663258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased neuronal damage in apolipoprotein E-deficient mice following global ischaemia.
    Horsburgh K; Kelly S; McCulloch J; Higgins GA; Roses AD; Nicoll JA
    Neuroreport; 1999 Mar; 10(4):837-41. PubMed ID: 10208557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The behavioural effect of middle cerebral artery occlusion on apolipoprotein-E deficient mice.
    Hatcher JP; Virley D; Hadingham SJ; Roberts J; Hunter AJ; Parsons AA
    Behav Brain Res; 2002 Apr; 131(1-2):139-49. PubMed ID: 11844581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combinatorial effect of probucol and cilostazol in focal ischemic mice with hypercholesterolemia.
    Kim JH; Park SH; Bae SS; Hong KW; Kim YD; Park KP; Choi BT; Shin HK
    J Pharmacol Exp Ther; 2011 Aug; 338(2):451-7. PubMed ID: 21546537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remote Limb Ischemic Conditioning during Cerebral Ischemia Reduces Infarct Size through Enhanced Collateral Circulation in Murine Focal Cerebral Ischemia.
    Kitagawa K; Saitoh M; Ishizuka K; Shimizu S
    J Stroke Cerebrovasc Dis; 2018 Apr; 27(4):831-838. PubMed ID: 29395650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimized protocol to reduce variable outcomes for the bilateral common carotid artery occlusion model in mice.
    Zhen G; Doré S
    J Neurosci Methods; 2007 Oct; 166(1):73-80. PubMed ID: 17692388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperlipidemia attenuates vascular endothelial growth factor-induced angiogenesis, impairs cerebral blood flow, and disturbs stroke recovery via decreased pericyte coverage of brain endothelial cells.
    Zechariah A; ElAli A; Hagemann N; Jin F; Doeppner TR; Helfrich I; Mies G; Hermann DM
    Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1561-7. PubMed ID: 23559636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein E isoform-specific differences in outcome from focal ischemia in transgenic mice.
    Sheng H; Laskowitz DT; Bennett E; Schmechel DE; Bart RD; Saunders AM; Pearlstein RD; Roses AD; Warner DS
    J Cereb Blood Flow Metab; 1998 Apr; 18(4):361-6. PubMed ID: 9538900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of lidocaine on brain damage induced by transient global cerebral ischemia in mice of different apolipoprotein E genotypes].
    Song PP; Wang DX; Wang PY
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(48):3401-8. PubMed ID: 16409860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Motheaten (me/me) mice deficient in SHP-1 are less susceptible to focal cerebral ischemia.
    Beamer CA; Brooks DM; Lurie DI
    J Neurosci Res; 2006 May; 83(7):1220-30. PubMed ID: 16528752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic mild reduction of cerebral perfusion pressure induces ischemic tolerance in focal cerebral ischemia.
    Kitagawa K; Yagita Y; Sasaki T; Sugiura S; Omura-Matsuoka E; Mabuchi T; Matsushita K; Hori M
    Stroke; 2005 Oct; 36(10):2270-4. PubMed ID: 16141423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer's disease model.
    Holtzman DM; Fagan AM; Mackey B; Tenkova T; Sartorius L; Paul SM; Bales K; Ashe KH; Irizarry MC; Hyman BT
    Ann Neurol; 2000 Jun; 47(6):739-47. PubMed ID: 10852539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.